BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28442604)

  • 1. Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R.
    Mitchell JK; Midkiff BR; Israelow B; Evans MJ; Lanford RE; Walker CM; Lemon SM; McGivern DR
    mBio; 2017 Apr; 8(2):. PubMed ID: 28442604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.
    Yoon CH; Kim SY; Byeon SE; Jeong Y; Lee J; Kim KP; Park J; Bae YS
    J Virol; 2015 Apr; 89(8):4262-80. PubMed ID: 25653431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.
    Liu R; Moss B
    J Virol; 2016 Sep; 90(17):7864-79. PubMed ID: 27334583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
    Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
    J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis.
    Poole MI; Sorribes I; Jain HV
    Math Biosci; 2018 Dec; 306():186-196. PubMed ID: 30312632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
    Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells.
    Alisi A; Mele R; Spaziani A; Tavolaro S; Palescandolo E; Balsano C
    J Cell Physiol; 2005 Oct; 205(1):25-31. PubMed ID: 15880455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection.
    Watanabe T; Hiasa Y; Tokumoto Y; Hirooka M; Abe M; Ikeda Y; Matsuura B; Chung RT; Onji M
    PLoS One; 2013; 8(7):e67750. PubMed ID: 23844083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Replication of Mouse Adenovirus Type 1 following Virus-Induced Degradation of Protein Kinase R (PKR).
    Goodman DE; Pretto CD; Krepostman TA; Carnahan KE; Spindler KR
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staufen1 promotes HCV replication by inhibiting protein kinase R and transporting viral RNA to the site of translation and replication in the cells.
    Dixit U; Pandey AK; Mishra P; Sengupta A; Pandey VN
    Nucleic Acids Res; 2016 Jun; 44(11):5271-87. PubMed ID: 27106056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
    Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
    Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells.
    Daito T; Watashi K; Sluder A; Ohashi H; Nakajima S; Borroto-Esoda K; Fujita T; Wakita T
    Gastroenterology; 2014 Aug; 147(2):463-72. PubMed ID: 24786893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
    Schweitzer CJ; Zhang F; Boyer A; Valdez K; Cam M; Liang TJ
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells.
    Zhang L; Alter HJ; Wang H; Jia S; Wang E; Marincola FM; Shih JW; Wang RY
    Virology; 2013 Mar; 438(1):28-36. PubMed ID: 23399035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.
    Kang W; Sung PS; Park SH; Yoon S; Chang DY; Kim S; Han KH; Kim JK; Rehermann B; Chwae YJ; Shin EC
    Gastroenterology; 2014 May; 146(5):1351-60.e1-4. PubMed ID: 24486950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Protein Kinase R Inhibition by Human Cytomegalovirus pTRS1.
    Vincent HA; Ziehr B; Moorman NJ
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus controls interferon production through PKR activation.
    Arnaud N; Dabo S; Maillard P; Budkowska A; Kalliampakou KI; Mavromara P; Garcin D; Hugon J; Gatignol A; Akazawa D; Wakita T; Meurs EF
    PLoS One; 2010 May; 5(5):e10575. PubMed ID: 20485506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
    J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.